Nanomix Corporation
OTC: NNMX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David Gerald Ludvigson
- Employees
- 30
- Headquarters
- Lawrence, United States
- IPO year
- 2021
- Market cap
- $9.8K
- Website
- https://www.bostonti.com
Loading NNMX…
Loading profile data…Frequently asked questions about NNMX
What does Nanomix Corporation (NNMX) do?
Boston Therapeutics, Inc. focuses on the discovery, production, and commercialization of therapeutic drugs aimed at fulfilling critical unmet medical needs in the areas of diabetes and inflammatory diseases. The company's pipeline features BTI-320, a non-systemic, carbohydrate-based tablet currently in Phase II clinical trials, which is being de...
Where does NNMX trade?
Nanomix Corporation (NNMX) trades on the Other OTC.
What sector is NNMX in?
Nanomix Corporation (NNMX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Nanomix Corporation?
David Gerald Ludvigson is the chief executive officer of Nanomix Corporation (NNMX).
Where is Nanomix Corporation headquartered?
Nanomix Corporation is headquartered in United States.
Does NNMX pay a dividend?
Nanomix Corporation (NNMX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNMX go public?
Nanomix Corporation (NNMX) completed its initial public offering in 2021.